These results, confirmed by Western blot analysis of cell lysates (Figure 1C & 1D), suggest E2 may modulate HLA-DR expression in ER− breast cancer through an ERα independent mechanism [46]. The gene discussed is ESR1; the disease is breast carcinoma.